N. prodotti: 0
Totale ordine: € 0,00
Indexed/Abstracted in: e-psyche, EMBASE, PubMed/MEDLINE, Neuroscience Citation Index, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,651
Online ISSN 1827-1855
Asadi-Pooya A. A. 1, 2, 3, Rakei S. M. 6, Kamgarpour A. 6, Taghipour M. 1, 6, Ashjazadeh N. 1, 2, Razmkon A. 1, 6, Zare Z. 5, Bagheri M. H. 4
1 Neurosciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran;
2 Department of Neurology, Shiraz Medical School, Shiraz University of Medical Sciences, Shiraz, Iran;
3 Jefferson Comprehensive Epilepsy Center, Department of Neurology, Thomas Jefferson University, Philadelphia, USA;
4 Medical Imaging Research Center, Department of Radiology, Namazee Hospital, Shiraz University of Medical Sciences, Shiraz, Iran;
5 Department of Radiology, Shiraz Medical School, Shiraz University of Medical Sciences, Shiraz, Iran;
6 Department of Neurosurgery, Shiraz Medical School, Shiraz University of Medical Sciences, Shiraz, Iran
AIM: Epilepsy surgery has been proved to be feasible and cost-effective in developing countries. In the current paper, we discussed the outcome of patients with mescal temporal lobe epilepsy (MTLE) and medically-refractory seizures who had surgery at our center in Shiraz, Iran.
METHODS: Patients 18 years of age and older with refractory MTLE and mescal temporal sclerosis operated at Namazee Hospital, Shiraz University of Medical Sciences, Shiraz, Iran from May 2009 through December 2011 were reviewed. Presurgical evaluation included clinical history, neurological examination, 2-hour Video-EEG recording, and 1.5-T MRI. All patients were submitted to standard temporal lobectomy at the side determined by MRI and Video-EEG.
RESULTS: Twenty-two patients (12 women and 10 men) had surgery between May 2009 and December 2011. All patients were followed postoperatively for at least 12 months (mean = 24.8 ± 7.7 months; minimum = 12 months; maximum = 36 months). At the last follow-up visit, 18 patients (81.8%) had a good outcome [15 patients (68.2%) had Engel class 1 and three others had Engel class 2]. The total cost of presurgical evaluation and epilepsy surgery at our center was less than 500 U.S. Dollars.
CONCLUSION: Resources are limited for the vast majority of medically-refractory patients with epilepsy who live in the developing countries. However, it is feasible to select good surgical candidates for anterior temporal lobectomy relying on the clinical history and examination, MRI and interictal EEG. Broader application of epilepsy surgery should be encouraged in countries with limited financial resources.